

[ Tue, Aug 01st 2017
] - WOPRAI

[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI

[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
[ Fri, Jul 28th 2017
] - WOPRAI
Kyle Rose Downgraded (ZBH) to Hold on, Jul 28th, 2017
Kyle Rose of Canaccord Genuity, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold on, Jul 28th, 2017.
Kyle has made no other calls on ZBH in the last 4 months.
There are 5 other peers that have a rating on ZBH. Out of the 5 peers that are also analyzing ZBH, 2 agree with Kyle's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Travis Steed of "Cantor Fitzgerald" Initiated at Hold and Held Target at $137 on, Friday, June 30th, 2017
- Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Hold on, Friday, April 28th, 2017
These are the ratings of the 3 analyists that currently disagree with Kyle
- David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Monday, July 17th, 2017
- Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017
- Isaac Ro of "Goldman Sachs" Initiated at Strong Sell and Held Target at $92 on, Tuesday, May 16th, 2017